Author

admin

Browsing

23andMe on Tuesday announced it will voluntarily delist from the Nasdaq and de-register with the U.S. Securities and Exchange Commission, according to a release. The move comes after Regeneron Pharmaceuticals said earlier this month that it will acquire “substantially all” of 23andMe’s assets for $256 million. The drugmaker came out…

Technology Back in Top-5 Last week’s market decline of 2-2.5% (depending on the index) has led to some notable shifts in sector performance and rankings. This pullback, coming after a strong rally, is changing the order of highs and lows on the weekly chart — a particularly significant development, at…

Get the latest stock market update with Mary Ellen McGonagle. Learn key downside signals, how to manage pullbacks, and which earnings reports could impact the market next week. In this week’s episode, Mary Ellen reviews where the markets currently stand and what to watch for to signal further downside. She…